Charles Schwab Investment Management Inc Omega Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$5.6 - $9.66 $364,621 - $628,972	65,111 New	65,111 $364,000
Q2 2022 Aug 15, 2022	SELL	$2.01 - $7.19 $106,125 - $379,624	-52,799 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$6.24 - $14.04 $207,336 - $466,507	33,227 Added 169.77%	52,799 $330,000
Q3 2021 Nov 16, 2021	BUY	$16.0 - $22.51 $313,152 - $440,565	19,572 New	19,572 $369,000

45.3M

36.9K

33.5K

Ticker OMGA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,853,400
Market Cap $63.2M
Description
Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.